Volume 9, Issue 3 (Aug 2021)                   Res Mol Med (RMM) 2021, 9(3): 189-196 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hosseini oula S K, Saeedinia A R, Zeinoddini M. The Modified Recombinant Proinsulin: A Simple and Efficient Way to Produce Insulin Glargine in E. coli. Res Mol Med (RMM) 2021; 9 (3) :189-196
URL: http://rmm.mazums.ac.ir/article-1-439-en.html
1- Faculty of Chemistry and Chemical Engineering, Malek Ashtar University of Technology, Tehran, Iran.
2- Faculty of Chemistry and Chemical Engineering, Malek Ashtar University of Technology, Tehran, Iran. , ar_saeedi@mut.ac.ir
Abstract:   (1843 Views)
Background: Recombinant insulin glargine, a long-acting analog of insulin, is expressed as proinsulin in the host cell and, after purification and refolding steps, is processed to mature insulin by using trypsin and carboxypeptidase B. Because of several internal residues of arginine and lysine in the proinsulin B
and C chains, several unwanted products are formed after treatment with these enzymes. To overcome this problem, we introduced three thrombin recognition sites into the proinsulin encoding sequence.
Materials and methods: After the design, the modified proinsulin encoding sequence containing the 5′ His-Tag tail and three thrombin recognition sites located between the His-Tag and B chain, B and C chains, and C and A chains, respectively, was synthesized by overlap extension Polymerase Chain Reaction (PCR) using seven specific primers in multiple sequential PCR reactions. The final amplified fragment was cloned in the pGEM-5zf vector by the EcoRV enzyme. After sequencing, the modified proinsulin encoding sequence was subcloned into the pET-26b(+) vector using NdeI and XhoI enzymes. Finally, the modified proinsulin was expressed in E. coli BL-21(DE3) by induction with Isopropyl β-d-1-thiogalactopyranoside (IPTG).
Results: The accuracy of the synthesized modified proinsulin sequence was confirmed by DNA sequencing. The modified proinsulin cloning was evaluated by PCR with specific primers and digestion with specific restriction enzymes. In this study, the modified proinsulin protein was expressed up to 40%. The modified proinsulin protein expression was assessed using sodium dodecyl Sulfate–Polyacrylamide Gel Electrophoresis (SDS-PAGE) and western blotting.
Conclusions: This modified proinsulin can be used to easily and efficiently produce insulin glargine without any impurities after processing with thrombin in one step in a nickel chromatographic column.
Full-Text [PDF 2330 kb]   (1481 Downloads)    
Type of Study: Research | Subject: Molecular biology
Published: 2021/08/20

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Designed & Developed by : Yektaweb